Companies/US/BBLG

BONE BIOLOGICS CORPORATION

Last · NasdaqCM$0.3875-0.0271 (-6.54%)live · yahoo · 3h ago
Vol 113.5K ≈ 44.0K
Market cap$1.07M2.8M sh
P/E · TTM-0.3fwd -0.6 · eps -1.27 · loss
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
$0.3788$2.70
Volume113.5Ksession

Issuer

Legal nameBONE BIOLOGICS CORPORATION
HQUnited States (US)
ListingUS BBLG
ISINUS0980706008
SectorHealthcare
IndustryHealthcare Products
SIC3842
CurrencyUSD
Entity registryisin:US0980706008
CIK0001419554
Employees2
AddressBone Biologics Corp. 2 Burlington Woods Drive 01803, Burlington
Loading chart…

OpenFilings analyst

Our analyst

10-K · 2026-03-02

From latest 10-K · 2026-03-02

  • Operating Cf Burn
  • Cash Runway Low
  • Accumulated Deficit High

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Cash Runway Low — Cash runway ~2.0 years
  • Accumulated Deficit High — Accumulated deficit / equity 1639%

Documents

FormReporting forFiledFlags
2026-09-282026-09-300
2026-09-282026-09-300
2026-09-282026-09-300
2026-09-282026-09-300